Discodermolide Synthesis via Lactone Ring Opening

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The supply of (+)-discodermolide, a potent anti-cancer agent, is limited due to its scarce natural availability and inefficient chemical synthesis methods, which require numerous steps and intermediates, hindering its production for clinical trials and research.

Innovation Solution

A novel and efficient synthesis method for discodermolide intermediates, specifically methyl ketone 4, is developed through ring opening and oxidation of hydroxy-protected lactones, reducing the number of steps from 11 to 3 and increasing yield, integrating into existing synthetic approaches like the Novartis synthesis.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional chemical synthesis methods are used to produce discodermolide, then the product can be obtained, but the synthesis requires numerous steps (11 linear steps for intermediate E) and has low efficiency

Engineering Contradiction:
Improvesynthesis efficiencyVSAvoidnumber of synthesis steps
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent applies preliminary action by pre-forming the lactone ring structure in the starting material (hydroxy lactone 1) with the correct stereochemical triad already in place. This pre-organization eliminates the need for multiple subsequent steps to establish these critical structural features, directly reducing the synthesis step count from 11 to 3 while maintaining product quality

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The synthesis is segmented into three distinct functional transformations: (1) ring opening of the lactone, (2) protection of the hydroxy group, and (3) oxidation to form the methyl ketone. This segmentation allows each step to be optimized independently and performed in sequence, improving overall productivity while reducing complexity compared to the conventional multi-step approach

Inventive Principle:
Principle #1Segmentation

2Quantity of substance

If conventional synthesis methods are used, then discodermolide can be produced, but the overall yield is low due to numerous synthesis steps

Engineering Contradiction:
ImproveyieldVSAvoidsynthesis process length
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

By pre-establishing the lactone ring with the correct stereochemistry in the starting material, the patent eliminates multiple yield-lossing steps. Each of the three proposed steps has high inherent yield, and fewer steps mean fewer opportunities for yield degradation, directly increasing the quantity of final product obtained

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent skips intermediate isolation and purification steps that are traditionally required in multi-step syntheses. The three transformations can be performed in a telescoped sequence, rushing through the synthesis process to minimize the cumulative loss of material that occurs with repeated isolation and purification operations

Inventive Principle:
Principle #21Skipping (Rushing through)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method significantly enhances the availability and efficiency of discodermolide synthesis by simplifying the production of key intermediates, decreasing the overall length and increasing the yield of the synthesis process, making more discodermolide available for clinical trials and research.

Implementation Method 1

ring opening a hydroxy-protected lactone to form an alcohol

Methodology Applied
Scientific EffectRing opening: Hydrolysis

Implementation Method 2

oxidizing alcohol to form methyl ketone

Methodology Applied
Scientific EffectOxidation: Oxidation

Data Source

PatentUS7348436B2Compounds useful for the synthesis of (+)-discodermolide and methods thereof
Publication Date: 2008.03.25 KOSAN BIOSCIENCES INC
  • US7348436B2 patent drawing
  • US7348436B2 patent drawing
  • US7348436B2 patent drawing

AI summary

Compounds and methods useful for the synthesis of (+)-discodermolide, a naturally occurring microtubule stabilizing agent useful as an anti-cancer agent.